Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree https://ir.compasspathways.com/News...6-Fierce-50-Breakthrough-Honoree/default.aspx Compass Pathways - Pushing psilocybin toward the medical mainstream https://www.fiercepharma.com/fierce-50/compass-pathways
Following major reforms, over 250K new Veterans enroll in VA healthcare in '26 https://news.va.gov/press-room/more...ans-enrolled-in-va-healthcare-so-far-in-2026/ "[Of the] 1.4 million completed or scheduled medical appointments with Veterans who joined in '26. That includes more than 300,000 mental health appointments.."
Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026 https://ir.compasspathways.com/News...HEOR-Data-at-Psych-Congress-2026/default.aspx
$CMPS Stock Movers: Chime, Boston Scientific, Compass Pathways @business https://www.bloomberg.com/news/audio/2026-09-08/stock-movers-chime-stryker-compass-pathways-podcast
$CMPS 2026 Cantor Global Healthcare Conference Fireside Chat in 5 minutes: https://sqps.onstreamsecure.com/ori...ntId=38636397&checkCompany=1&checkEmail=1&che
Updated link for Cantor Fireside Chat: https://sqps.onstreamsecure.com/ori...venPlayer.html?customerId=22&eventId=38636397
RFK Jr.’s movement now has corporate sponsors The upcoming Make America Healthy Again Summit is brought to you by companies with business before the Health Department. https://www.politico.com/news/2026/09/20/maha-rfk-summit-walmart-anthropic-openai-01084806 -- I read the Politico piece alongside the Bloomberg reporting and the current MAHA Summit agenda. My view is that it makes the access/optics issue more substantial, but it still does not provide evidence that COMP360 or DT120 is receiving preferential FDA review. Those are two very different propositions. Politico’s framing is broader than Bloomberg’s. The official September 29 agenda currently places: Kabir Nath — Compass CEO Rob Barrow — Definium CEO Michael Halstead — Helus CEO Matt Zorn — Deputy General Counsel, HHS together for “Psychedelic Medicine, the Next Frontier.” And immediately around that conference are sessions dealing with “Modernizing the FDA,” CMS reform, healthcare affordability, insurance, AI/healthcare and federal health policy. The FDA session currently lists White House adviser Calley Means and acting FDA Commissioner Kyle Diamantas, with Diamantas marked invited/pending confirmation; CMS Administrator Oz is similarly listed as invited/pending confirmation for the CMS panel. So psychedelics aren't being presented on the fringe of this event. They're embedded in a conference involving the organizations that potentially have to answer the post-approval implementation questions. $DFTX $CMPS are big winners here in the space.
